{"abdominal abscess": 26.5, "abnormal behaviour": 2.5, "acute kidney injury": 2.0, "acute lymphocytic leukaemia": 20.32, "acute myeloid leukaemia": 5.0, "acute respiratory distress syndrome": 4.26, "anaemia": 2.93, "brain oedema": 3.93, "bronchopulmonary aspergillosis": 10.22, "candida infection": 7.3, "cardiac failure": 2.04, "cardiogenic shock": 3.95, "clostridium difficile infection": 4.69, "cytomegalovirus infection": 4.88, "cytomegalovirus infection reactivation": 21.24, "cytopenia": 16.81, "disease progression": 6.24, "disease recurrence": 2.06, "drug eruption": 2.06, "drug ineffective": 2.28, "drug ineffective for unapproved indication": 4.98, "drug intolerance": 2.68, "drug reaction with eosinophilia and systemic symptoms": 2.09, "drug resistance": 5.95, "enterococcal infection": 27.57, "febrile neutropenia": 9.53, "haematotoxicity": 8.39, "hepatitis b reactivation": 19.65, "hypercalcaemia": 6.87, "hypogammaglobulinaemia": 18.42, "ileus paralytic": 10.3, "infection": 5.02, "infusion related reaction": 4.82, "intentional product use issue": 2.53, "klebsiella infection": 28.85, "leukopenia": 2.67, "lower respiratory tract infection": 3.01, "lymphopenia": 6.5, "maligt neoplasm progression": 2.71, "metapneumovirus infection": 119.05, "mucosal inflammation": 9.03, "multiple organ dysfunction syndrome": 3.5, "myelodysplastic syndrome": 9.93, "myelosuppression": 6.13, "neuropathy peripheral": 16.66, "neurotoxicity": 5.14, "neutropenia": 6.84, "neutrophil count decreased": 2.15, "off label use": 3.41, "pancytopenia": 6.16, "paranoia": 5.1, "peripheral sensory neuropathy": 39.14, "plasma cell leukaemia": 202.59, "plasma cell myeloma": 100.51, "plasma cell myeloma recurrent": 168.26, "plasma cell myeloma refractory": 528.86, "plasmacytoma": 127.73, "platelet count decreased": 2.96, "pneumonia": 3.3, "polyneuropathy": 26.97, "polyomavirus-associated nephropathy": 54.21, "posterior reversible encephalopathy syndrome": 19.75, "product use in unapproved indication": 3.55, "progressive multifocal leukoencephalopathy": 18.81, "proteinuria": 2.06, "pulmonary oedema": 2.48, "respiratory failure": 2.38, "respiratory tract infection": 4.11, "sepsis": 5.82, "septic shock": 4.87, "shock": 2.0, "staphylococcal bacteraemia": 31.11, "staphylococcal sepsis": 18.11, "therapeutic product effect incomplete": 6.25, "therapeutic response decreased": 6.56, "therapy non-responder": 10.54, "therapy partial responder": 26.82, "thrombocytopenia": 7.35, "thrombotic microangiopathy": 15.51, "treatment failure": 6.29, "tumour lysis syndrome": 25.04, "vascular device infection": 13.86, "white blood cell count decreased": 2.11}